Cargando…

Evidence for the active intermediate in cyclophosphamide metabolism.

Detalles Bibliográficos
Autor principal:	Cox, P. J.
Formato:	Texto
Lenguaje:	English
Publicado:	Nature Publishing Group 1973
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2009050/ https://www.ncbi.nlm.nih.gov/pubmed/4737506

Ejemplares similares

Effects of the induction of hepatic microsomal metabolism on the toxicity of cyclophosphamide.
por: Gurtoo, H. L., et al.
Publicado: (1985)

Cimetidine enhancement of cyclophosphamide antitumour activity.
por: Dorr, R. T., et al.
Publicado: (1982)

Genetically engineered V79 Chinese hamster cells metabolically activate the cytostatic drugs cyclophosphamide and ifosfamide.
por: Doehmer, J, et al.
Publicado: (1990)

Lipidomics of cyclophosphamide 4‐hydroxylation in patients receiving post‐transplant cyclophosphamide
por: Navarro, Sandi L., et al.
Publicado: (2022)

Distribution and pharmacokinetics of cyclophosphamide in the rat.
por: Talha, M. R., et al.
Publicado: (1980)

Topotecan and Cyclophosphamide in Adults with Relapsed Sarcoma
por: Blanchette, P., et al.
Publicado: (2012)

Thermochemotherapy-induced resistance to cyclophosphamide.
por: Urano, M., et al.
Publicado: (1988)

Low-Dose Cyclophosphamide Synergizes with Dendritic Cell-Based Immunotherapy in Antitumor Activity
por: Veltman, Joris D., et al.
Publicado: (2010)

The effect of cyclophosphamide on Fas-mediated apoptosis.
por: Lee, J. H., et al.
Publicado: (1997)

Cytotoxicity of cyclophosphamide in the rat incisor.
por: Adatia, A. K.
Publicado: (1975)

Role of metabolites of cyclophosphamide in cardiotoxicity
por: Kurauchi, Koichiro, et al.
Publicado: (2017)

Phase I/pharmacokinetic/biochemical study of the nitroimadazole hypoxic cell sensitiser SR2508 (etanidazole) in combination with cyclophosphamide.
por: O'Dwyer, P. J., et al.
Publicado: (1993)

Metabolic Intermediates in Tumorigenesis and Progression
por: He, Yuchen, et al.
Publicado: (2019)

A Review of Cyclophosphamide
por: Fox, B. W.
Publicado: (1975)

Resistance of human T-CFUcs to activated cyclophosphamide: a feature common with critical marrow stem cells?
por: Byfield, J. E., et al.
Publicado: (1985)

The effect of cyclophosphamide on MSV-H oncogenesis.
por: Branca, M., et al.
Publicado: (1977)

Mycophenolate versus Cyclophosphamide for Lupus Nephritis
por: Sahay, M., et al.
Publicado: (2018)

The effect of radiosensitizers on the pharmacokinetics of melphalan and cyclophosphamide in the mouse.
por: Hinchliffe, M., et al.
Publicado: (1983)

Cyclophosphamide-Induced Lung Injury
por: Pugh, Dan, et al.
Publicado: (2018)

The Effect of Cysteine on the Immunosuppressive Activity of Busulphan, Cyclophosphamide and Nitrogen Mustard
por: Addison, I. E., et al.
Publicado: (1971)

Isoliquiritigen Enhances the Antitumour Activity and Decreases the Genotoxic Effect of Cyclophosphamide
por: Zhao, Hong, et al.
Publicado: (2013)

Immunomodulatory Activity of Carboxymethyl Pachymaran on Immunosuppressed Mice Induced by Cyclophosphamide
por: Liu, Feng, et al.
Publicado: (2021)

Isophosphoramide mustard, a metabolite of ifosfamide with activity against murine tumours comparable to cyclophosphamide.
por: Struck, R. F., et al.
Publicado: (1983)

Is there any difference between busulfan-cyclophosphamide and cyclophosphamide-busulfan in patients underwent allogeneic transplantation?
por: Bahçecioğlu, Ömer Faruk, et al.
Publicado: (2021)

Enhancing effect of misonidazole on the response of the RIF-1 tumour to cyclophosphamide.
por: Law, M. P., et al.
Publicado: (1981)

Structural Evidence for a Copper-Bound Carbonate Intermediate in the Peroxidase and Dismutase Activities of Superoxide Dismutase
por: Strange, Richard W., et al.
Publicado: (2012)

Cyclophosphamide causes osteoporosis in C57BL/6 male mice: suppressive effects of cyclophosphamide on osteoblastogenesis and osteoclastogenesis
por: Zhao, Dongfeng, et al.
Publicado: (2017)

Comparative study of adjuvant chemotherapeutic efficacy of docetaxel plus cyclophosphamide and doxorubicin plus cyclophosphamide in female breast cancer
por: Adeel, Muhammad, et al.
Publicado: (2019)

Cyclophosphamide: Death: case report
Publicado: (2021)

Cyclophosphamide: Thrombocytopenia: case report
Publicado: (2021)

Enhancement of cyclophosphamide cytotoxicity in vivo by the benzamide analogue pyrazinamide.
por: Horsman, M. R., et al.
Publicado: (1994)

Photoreactions of cyclic sulfite esters: Evidence for diradical intermediates
por: White, Rick C, et al.
Publicado: (2012)

A bioassay for cyclophosphamide in blood, lung and tumour.
por: Begg, A. C., et al.
Publicado: (1984)

Cyclophosphamide in pulmonary alveolar hemorrhage due to leptospirosis
por: Trivedi, Samir V., et al.
Publicado: (2009)

Cyclophosphamide Increases Lactobacillus in the Intestinal Microbiota in Chickens
por: Mesa, Dany, et al.
Publicado: (2020)

Modification of tumour and host response to cyclophosphamide by misonidazole and by WR 2721.
por: Twentyman, P. R.
Publicado: (1981)

Cellular mechanisms of cyclophosphamide-induced taste loss in mice
por: Mukherjee, Nabanita, et al.
Publicado: (2017)

METABOLIC INTERMEDIATES IN ADAPTIVE FERMENTATION OF GALACTOSE BY YEAST
por: Reiner, John M.
Publicado: (1947)

Further evidence for charged intermediate vector bosons at the SPS collider
por: Arnison, Geoffrey T J, et al.
Publicado: (1985)

No evidence for schistosome parasite fitness trade-offs in the intermediate and definitive host
por: Le Clec’h, Winka, et al.
Publicado: (2023)

Cannot write session to /tmp/vufind_sessions/sess_had07dq8b137l1vgiqhrebndfm